Mechanisms of Erythropoietin-induced Brain Protection in Neonatal Hypoxia-Ischemia Rat Model
暂无分享,去创建一个
John H. Zhang | Yun Sun | A. Nanda | Changman Zhou | P. Polk
[1] Pierre J Magistretti,et al. Lactate is a Preferential Oxidative Energy Substrate over Glucose for Neurons in Culture , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] Ç. Ulukuş,et al. Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats , 2003, Neonatology.
[3] M. Buemi,et al. The Pleiotropic Effects of Erythropoietin in the Central Nervous System , 2003, Journal of neuropathology and experimental neurology.
[4] F. Barone,et al. Caspase 3 activation is essential for neuroprotection in preconditioning , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] John H. Zhang,et al. A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat , 2003, Brain Research.
[6] J. Fisher,et al. Erythropoietin: Physiology and Pharmacology Update 2 , 2003, Experimental biology and medicine.
[7] Kenneth Maiese,et al. Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases , 2002, Circulation.
[8] T. Eid,et al. Recombinant human erythropoietin for neuroprotection: what is the evidence? , 2002, Clinical breast cancer.
[9] U. Dirnagl,et al. Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model , 2002, The Journal of Neuroscience.
[10] J. LaManna,et al. Activation of Hypoxia-Inducible Factor-1 in the Rat Cerebral Cortex after Transient Global Ischemia: Potential Role of Insulin-Like Growth Factor-1 , 2002, The Journal of Neuroscience.
[11] P. Ghezzi,et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis , 2002, Brain Research.
[12] John H. Zhang,et al. Hyperbaric oxygenation prevented brain injury induced by hypoxia–ischemia in a neonatal rat model , 2002, Brain Research.
[13] M. Buemi,et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection. , 2002, Clinical science.
[14] John H. Zhang,et al. Mechanism of RhoA/Rho kinase activation in endothelin-1- induced contraction in rabbit basilar artery. , 2002, American journal of physiology. Heart and circulatory physiology.
[15] S. Juul,et al. Erythropoietin in the central nervous system, and its use to prevent hypoxic‐ischemic brain damage , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[16] P. Lewczuk,et al. Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.
[17] John H. Zhang,et al. Oxyhemoglobin produces necrosis, not apoptosis, in astrocytes , 2002, Brain Research.
[18] D. Butterfield,et al. Molecular Chaperones and Their Roles in Neural Cell Differentiation , 2002, Developmental Neuroscience.
[19] A. Cerami,et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Grimm,et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration , 2002, Nature Medicine.
[21] K. Maiese,et al. Hematopoietic Factor Erythropoietin Fosters Neuroprotection through Novel Signal Transduction Cascades , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] E. Mackenzie,et al. Normobaric Hypoxia Induces Tolerance to Focal Permanent Cerebral Ischemia in Association with an Increased Expression of Hypoxia-Inducible Factor-1 and its Target Genes, Erythropoietin and VEGF, in the Adult Mouse Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] J. McIntyre,et al. Recent advances in neonatology , 2002, Current opinion in obstetrics & gynecology.
[24] R. Hata,et al. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up‐regulating Bcl‐xL expression , 2002, Journal of neuroscience research.
[25] A. Ruello,et al. Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia. , 2002, Journal of nephrology.
[26] F. Tomasello,et al. Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage? , 2002, Journal of neurosurgery.
[27] E. Wintour,et al. Quantitation of the mRNA levels of Epo and EpoR in various tissues in the ovine fetus , 2002, Molecular and Cellular Endocrinology.
[28] F. Squadrito,et al. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. , 2002, European journal of pharmacology.
[29] A. Cerami,et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Ashwal,et al. Animal models of neonatal stroke , 2001, Current opinion in pediatrics.
[31] D. Ferriero. Oxidant Mechanisms in Neonatal Hypoxia-Ischemia , 2001, Developmental Neuroscience.
[32] Stuart A. Lipton,et al. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.
[33] A. Cerami,et al. Beyond erythropoiesis: novel applications for recombinant human erythropoietin. , 2001, Seminars in hematology.
[34] S. Raz,et al. Neonatal hypoxic risk in preterm birth infants: the influence of sex and severity of respiratory distress on cognitive recovery. , 2001, Neuropsychology.
[35] John H. Zhang,et al. Oxyhemoglobin induces caspase‐mediated cell death in cerebral endothelial cells , 2001, Journal of neurochemistry.
[36] Changlian Zhu,et al. Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia , 2001, The Journal of Biological Chemistry.
[37] S. Juul,et al. The Biology of Erythropoietin in the Central Nervous System and Its Neurotrophic and Neuroprotective Potential , 2001, Neonatology.
[38] P. Lewczuk,et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Hori,et al. Protective and regenerative response endogenously induced in the ischemic brain. , 2001, Canadian journal of physiology and pharmacology.
[40] G. Grasso,et al. Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. , 2001, Journal of neurosurgical sciences.
[41] John H. Zhang,et al. Caspase Inhibitors Attenuate Oxyhemoglobin-Induced Apoptosis in Endothelial Cells , 2001, Stroke.
[42] J. Fandrey,et al. Erythropoietin gene expression in different areas of the developing human central nervous system. , 2000, Brain research. Developmental brain research.
[43] V. Miller. Neonatal cerebral infarction. , 2000, Seminars in pediatric neurology.
[44] F. Tomasello,et al. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. , 2000, European journal of pharmacology.
[45] M. Bernaudin,et al. Neuroprotection and Angiogenesis: Dual Role of Erythropoietin in Brain Ischemia. , 2000, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[46] H. Mohrenweiser,et al. Production and processing of erythropoietin receptor transcripts in brain. , 2000, Brain research. Molecular brain research.
[47] P Ghezzi,et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] G. Semenza,et al. Role of hypoxia‐inducible factor‐1 in hypoxia‐induced ischemic tolerance in neonatal rat brain , 2000, Annals of neurology.
[49] S. Juul,et al. Nonerythropoietic roles of erythropoietin in the fetus and neonate. , 2000, Clinics in perinatology.
[50] M. Gassmann,et al. Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation , 2000 .
[51] A. Allegra,et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. , 2000, European journal of pharmacology.
[52] A. Allegra,et al. Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[53] S. Juul,et al. Erythropoietin in the Cerebrospinal Fluid of Neonates Who Sustained CNS Injury , 1999, Pediatric Research.
[54] C. Wagner,et al. The use of hypothermia: a role in the treatment of neonatal asphyxia? , 1999, Pediatric neurology.
[55] J. Rennie,et al. Recent advances in neonatology , 1999, Archives of disease in childhood. Fetal and neonatal edition.
[56] E. Mackenzie,et al. A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[57] S. Juul,et al. Erythropoietin in the neonate. , 1999, Current problems in pediatrics.
[58] A. Rojiani,et al. Immunohistochemical Localization of Erythropoietin and Its Receptor in the Developing Human Brain , 1999, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[59] J. Connor,et al. Rat model of perinatal hypoxic‐ischemic brain damage , 1999, Journal of neuroscience research.
[60] A. Shah,et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. , 1998, The Journal of clinical investigation.
[61] E. Morishita,et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[62] R. Vannucci,et al. A model of Perinatal Hypoxic‐Ischemic Brain Damage a , 1997, Annals of the New York Academy of Sciences.
[63] S. Peterec,et al. Management of neonatal Rh disease. , 1995, Clinics in perinatology.
[64] M. Gassmann,et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[65] R. Burke,et al. Localization of c-fos, c-jun, and hsp70 mRNA expression in brain after neonatal hypoxia-ischemia. , 1994, Brain research. Developmental brain research.
[66] T. Nowak,et al. The Heat Shock/Stress Response in Focal Cerebral Ischemia , 1994, Brain pathology.
[67] K. Kogure,et al. Altered Gene Expression in Cerebral Ischemia , 1993, Stroke.
[68] R. Burke,et al. Immediate early gene induction after neonatal hypoxia-ischemia. , 1993, Brain research. Molecular brain research.
[69] M. Goldberg,et al. Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. , 1991, The Journal of biological chemistry.
[70] R. Vannucci. Current and potentially new management strategies for perinatal hypoxic-ischemic encephalopathy. , 1990, Pediatrics.
[71] D. Ferriero,et al. Hypoxia-ischemia induces heat shock protein-like (HSP72) immunoreactivity in neonatal rat brain. , 1990, Brain research. Developmental brain research.
[72] B. Dwyer,et al. Synthesis of the major inducible heat shock protein in rat hippocampus after neonatal hypoxia-ischemia , 1989, Experimental Neurology.
[73] K. Raivio,et al. Prediction of perinatal brain damage by cord plasma vasopressin, erythropoietin, and hypoxanthine values. , 1988, The Journal of pediatrics.
[74] J. Rice,et al. The influence of immaturity on hypoxic‐ischemic brain damage in the rat , 1981, Annals of neurology.
[75] E. Kaptanoğlu,et al. Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain , 2002, Child's Nervous System.
[76] G. Acs,et al. Erythropoietin and erythropoietin receptor expression in human cancer. , 2001, Cancer research.
[77] A. Mureşan,et al. The brain and other sites of erythropoietin production. , 2000, Romanian journal of physiology : physiological sciences.
[78] M. Gassmann,et al. Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation. , 2000, Blood.
[79] John H. Zhang,et al. Oxyhemoglobin produces necrosis in cultured smooth muscle cells. , 2000, Acta neurochirurgica. Supplement.
[80] R. Keep,et al. Thrombin preconditioning, heat shock proteins and thrombin-induced brain edema. , 2000, Acta neurochirurgica. Supplement.
[81] 貞本 泰孝. Erythropoietin Prevents Place Navigation Disability and Cortical Infarction in Rats with Permanent Occlusion of the Middle Cerebral Artery , 2000 .
[82] Yan Li,et al. Erythropoietin and Erythropoietin Receptor in the Developing Human Central Nervous System , 1998, Pediatric Research.
[83] K. Eckardt. The ontogeny of the biological role and production of erythropoietin , 1995, Journal of perinatal medicine.
[84] J. Goddard-finegold,et al. Cerebrovascular regulation and neonatal brain injury. , 1991, Pediatric neurology.
[85] A. Maxwell,et al. Subcutaneous erythropoietin therapy and hypertensive encephalopathy. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.